Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Italy / NCT03441659
Recruiting Observational

ACL Reconstruction: Clinical Outcome

NCT03441659 · tracked via the Priya Life Science Italy tracker
Sponsor
Stefano Zaffagnini
Phase
Observational
Started
2020-12-17
Last updated
2026-07-09

Condition(s) studied

ACL Injury

Investigational drug(s) / intervention(s)

ACL reconstruction

ACL reconstruction: Surgical ACL reconstruction

Study summary

The study is intended to include all patients who will undergo surgical reconstruction of the anterior cruciate ligament (ACL). The patients will be monitored and evaluated preoperatively and also at 6 months and 1, 2 and 5 years after the intervention through a clinical visit or telephone interview. Such assessments will include the administration of questionnaires to determine the patient's functional symptoms and the objective examination of the knee during a medical examination to quantify its stability.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: 1. Patients who have provided informed written written consent; 2. Patients aged between 18 and 60; 3. Patients undergoing reconstructive surgical treatment of the anterior cruciate ligament (ACL) Exclusion Criteria: 1. Patients unable to understand and to want; 2. Patients who have not signed informed consent;

Primary outcome measure(s)

  • Knee Laxity Assessment — 5 years
    Laxity Evaluation with KiRA device

Trial sites (1)

FacilityCityRegionStatus
Stefano Zaffagnini Bologna Italia Recruiting

More Stefano Zaffagnini trials in Italy

Clinical and Biomechanical Outcomes of Anterior Cruciate Ligament (ACL) Reconstruction Associated With Lateral Extra-articular Tenodesis (LET) Recruiting
Biological Evaluation of Orthopedic Materials: An In Vitro Study Using Patient-Derived Human Samples Starting soon
Outcomes and Complication Rates of Anterior Cruciate Ligament Reconstruction Using the "Over-the-top" Technique Combined With Lateral Extra-articular Tenodesis in Patients Over 50 Years Old, Compared With a Control Group of Patients Under 30 Recruiting
Clinical-instrumental Evaluation and Assessment of Return to Sports Activity in Patients Surgically Treated for Isolated "Stener-like" Lesions of the Medial Collateral Ligament (MCL) or in the Context of Multiligament Injuries and Articular Fractures Recruiting
Study of Functional Magnetic Resonance Signal Variations in Patients Undergoing Anterior Cruciate Ligament Reconstruction With the Application of a Dedicated Neuromotor Training Recruiting

Other trials for the same condition

ACL Reconstruction with a New Generation of LARS Artificial Ligament Active, not recruiting
ACL Reconstruction in Patients Aged 50 Years and Older Active, not recruiting
Study of Functional Magnetic Resonance Signal Variations in Patients Undergoing Anterior Cruciate Ligament Reconstruction With the Application of a Dedicated Neuromotor Training Recruiting
Intraoperative Energy Expenditure During ACL Reconstruction Surgery Recruiting
Anterior Cruciate Ligament Study Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03441659 on ClinicalTrials.gov ↗ ← All trials in Italy